Nothing dramatic, just a weird pivot during a play
Clinicians advise caution until controlled trials confirm benefits and safety
Description Overview 5-Amino-1MQ is a selective NNMT inhibitor that elevates cellular NAD+ and SAM to enhance mitochondrial function, fat oxidation, insulin sensitivity, and overall metabolic efficiency, with preclinical data indicating preferential visceral fat loss and a favorable safety profile
Products sold online as 'AOD 9604' are frequently of unknown purity, concentration, and sterility meaning the risks extend well beyond those observed in controlled research settings
No therapeutic claims are made
Individuals with a known allergy to NAD+ or its preparation components must avoid this therapy